GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Symbion Health Ltd (ASX:SY1) » Definitions » Beneish M-Score

Symbion Health (ASX:SY1) Beneish M-Score : 0.00 (As of Jun. 21, 2024)


View and export this data going back to . Start your Free Trial

What is Symbion Health Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Symbion Health's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Symbion Health was 0.00. The lowest was 0.00. And the median was 0.00.


Symbion Health Beneish M-Score Historical Data

The historical data trend for Symbion Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symbion Health Beneish M-Score Chart

Symbion Health Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Symbion Health Semi-Annual Data
Jun95 Jun96 Jun97 Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Symbion Health's Beneish M-Score

For the Healthcare Plans subindustry, Symbion Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Symbion Health's Beneish M-Score Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Symbion Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Symbion Health's Beneish M-Score falls into.



Symbion Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Symbion Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8917+0.528 * -1.2412+0.404 * 1.0036+0.892 * 1.112+0.115 * 0.9502
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8983+4.679 * -0.037957-0.327 * 0.9838
=-3.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun07) TTM:Last Year (Jun06) TTM:
Total Receivables was A$230.21 Mil.
Revenue was A$3,826.37 Mil.
Gross Profit was A$1,130.37 Mil.
Total Current Assets was A$723.95 Mil.
Total Assets was A$2,225.91 Mil.
Property, Plant and Equipment(Net PPE) was A$239.16 Mil.
Depreciation, Depletion and Amortization(DDA) was A$51.18 Mil.
Selling, General, & Admin. Expense(SGA) was A$715.65 Mil.
Total Current Liabilities was A$650.11 Mil.
Long-Term Debt & Capital Lease Obligation was A$598.87 Mil.
Net Income was A$91.42 Mil.
Gross Profit was A$1.18 Mil.
Cash Flow from Operations was A$174.73 Mil.
Total Receivables was A$232.18 Mil.
Revenue was A$3,441.11 Mil.
Gross Profit was A$-1,261.75 Mil.
Total Current Assets was A$696.15 Mil.
Total Assets was A$2,164.48 Mil.
Property, Plant and Equipment(Net PPE) was A$244.85 Mil.
Depreciation, Depletion and Amortization(DDA) was A$49.26 Mil.
Selling, General, & Admin. Expense(SGA) was A$716.50 Mil.
Total Current Liabilities was A$636.59 Mil.
Long-Term Debt & Capital Lease Obligation was A$597.93 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(230.21 / 3826.369) / (232.178 / 3441.112)
=0.060164 / 0.067472
=0.8917

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(-1261.746 / 3441.112) / (1130.369 / 3826.369)
=-0.366668 / 0.295416
=-1.2412

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (723.949 + 239.16) / 2225.908) / (1 - (696.149 + 244.846) / 2164.481)
=0.567319 / 0.565256
=1.0036

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3826.369 / 3441.112
=1.112

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(49.26 / (49.26 + 244.846)) / (51.18 / (51.18 + 239.16))
=0.167491 / 0.176276
=0.9502

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(715.65 / 3826.369) / (716.495 / 3441.112)
=0.187031 / 0.208216
=0.8983

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((598.87 + 650.105) / 2225.908) / ((597.926 + 636.587) / 2164.481)
=0.561108 / 0.570351
=0.9838

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(91.419 - 1.178 - 174.729) / 2225.908
=-0.037957

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Symbion Health has a M-score of -3.82 suggests that the company is unlikely to be a manipulator.


Symbion Health Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Symbion Health's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Symbion Health (ASX:SY1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Symbion Group Limited (SYB, formerly Mayne Group Limited) is a healthcare-focused company comprised of 5 divisions: Pathology; Medical Centres; Imaging; Pharmacy Services; and Symbion Consumer.

Symbion Health (ASX:SY1) Headlines

No Headlines